Home/Filings/4/0001104659-24-108703
4//SEC Filing

Nashat Amir 4

Accession 0001104659-24-108703

CIK 0001736730other

Filed

Oct 14, 8:00 PM ET

Accepted

Oct 15, 5:49 PM ET

Size

24.9 KB

Accession

0001104659-24-108703

Insider Transaction Report

Form 4
Period: 2024-10-15
Nashat Amir
Director10% Owner
Transactions
  • Conversion

    Series B Preferred Stock

    2024-10-15277,5360 total(indirect: See Footnote)
    Common Stock (24,745 underlying)
  • Conversion

    Common Stock

    2024-10-15+1,250,0611,250,061 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2024-10-15+87,44887,448 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2024-10-15+353,7181,603,779 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2024-10-15+24,745112,193 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2024-10-15$11.00/sh+909,090$9,999,990909,090 total(indirect: See Footnote)
  • Conversion

    Series A Prime Preferred Stock

    2024-10-1514,020,4750 total(indirect: See Footnote)
    Common Stock (1,250,061 underlying)
  • Conversion

    Series B Preferred Stock

    2024-10-153,967,2340 total(indirect: See Footnote)
    Common Stock (353,718 underlying)
  • Conversion

    Series A Prime Preferred Stock

    2024-10-15980,8290 total(indirect: See Footnote)
    Common Stock (87,448 underlying)
Footnotes (7)
  • [F1]On October 15, 2024, the shares of Series A Prime Convertible Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.
  • [F2]The reported securities are owned directly by Polaris Partners VII, L.P. ("PP VII"). Polaris Management Co. VII, L.L.C. ("PMC VII") is the general partner of PP VII. Each of David Barrett, Brian Chee, the Reporting Person, a member of the Issuer's board of directors, and Bryce Youngren (collectively, the "PMC VII Managing Members") are the managing members of PMC VII. Each of PMC VII and the PMC VII Managing Members, including the Reporting Person, in their respective capacities with respect to PMC VII, may be deemed to have shared voting, investment and dispositive power with respect to the securities held by PP VII.
  • [F3]Each of PMC VII and the PMC VII Managing Members, including the Reporting Person, disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of the PMC VII Managing Members or PMC VII is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
  • [F4]On October 15, 2024, the shares of Series B Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.
  • [F5]The reported securities are owned directly by Polaris Entrepreneurs' Fund VII, L.P. ("PEF VII"). PMC VII is the general partner of PEF VII. Each of PMC VII and the PMC VII Managing Members, including the Reporting Person, in their respective capacities with respect to PMC VII, may be deemed to have shared voting, investment and dispositive power with respect to the securities held by PEF VII. Each of PMC VII and the PMC VII Managing Members, including the Reporting Person, disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of the PMC VII Managing Members, including the Reporting Person, or PMC VII is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
  • [F6]The reported securities are owned directly by Polaris Partners X, L.P. ("PP X"). Polaris Partners GP X, L.L.C. ("PPGP X") is the general partner of PP X. Each of Amy Schulman and Brian Chee are the managing members of PPGP X (the "PPGP X Managing Members"). The Reporting Person, a member of the Issuer's board of directors, is an interest holder of PPGP X. Each of PPGP X, the PPGP X Managing Members and the Reporting Person, in their respective capacities with respect to PPGP X, may be deemed to have shared voting, investment and dispositive power with respect to the securities held by PP X.
  • [F7]Each of PPGP X, the PPGP X Managing Members and the Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of the PPGP X Managing Members, the Reporting Person or PPGP X is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.

Issuer

Camp4 Therapeutics Corp

CIK 0001736730

Entity typeother

Related Parties

1
  • filerCIK 0001575843

Filing Metadata

Form type
4
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 5:49 PM ET
Size
24.9 KB